Phase 2 clinical program in cholangiocarcinoma expected to start first half of 2022
BCI Pharma enters into strategic partnership with Mithra to identify novel therapy for endometriosis and cancer in women
BCI Pharma seeks to expand its library of kinase inhibitors and address innovative mechanisms of action for unmet medical needs
Contipharma launches saliva-based Omicron detecting PCR test in Africa
Developed by University of Liège in Belgium, only test of its kind available on African continent
First contracts signed with Democratic Republic of Congo, Burundi and Sudan
Limbach Group adopts QuantaMatrix dRAST™ in routine clinical use
QuantaMatrix’s direct Rapid Antimicrobial Susceptibility Testing system (dRAST) improves optimal prescription of antibiotics by two days compared to conventional methods
Following successful validation of dRAST platform in Europe at key reference laboratories, system now adopted for clinical use
Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of Biofit
The Belgian start-up is developing an effective and reproducible phage therapy approach that offers a personalized solution to the major issue of AntiMicrobial Resistance (AMR)
Ferrer and CNIC unveil results of first real-world study of cnic-polypill showing decreased risk of major adverse cardiovascular events when compared to monocomponents administered separately
Advent France Biotechnology becomes AdBio partners
New name reflects venture capital firm’s international expansion as group of entrepreneur-investors adding value in biotech
Name change follows launch of second fund in September 2021 with first close at €86M aimed at building tomorrow’s most promising biotech start-ups
HypnoVR raises €4.5 million to accelerate the roll out of its digital therapy treating pain and anxiety
Series A funding round will allow company to accelerate international roll-out and extend scope of application of virtual reality-based medical hypnosis solution, used by healthcare professionals to treat pain and anxiety
Genoskin launches MANTIS, a spatial biology imaging platform dedicated to skin immunology
MANTIS (Multiplex ANnotated Tissue Imaging System) was developed at Infinity (Inserm U1291, France) by Dr. Nicolas Gaudenzio and his team; Dr. Gaudenzio was recently appointed as Genoskin’s Chief Scientific Officer (CSO)
Genoskin licensed intellectual property from Inserm to develop MANTIS as a spatial biology platform dedicated to skin immunology and to characterizing drug effects on human skin
